Dashboard
Manage Tickers

ALGSAligos Therapeutics, Inc.

Nasdaq www.aligos.com


$ 0.80 $ -0.05 (-5.44 %)    

Friday, 03-May-2024 10:29:13 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.88 $ 1.56 (0.36 %)
DIA $ 385.68 $ -1.02 (-0.26 %)
SPY $ 509.70 $ -0.83 (-0.16 %)
TLT $ 89.61 $ -0.51 (-0.57 %)
GLD $ 212.38 $ -1.04 (-0.49 %)
$ 0.846
$ 0.82
$ 0.00 x 0
$ 0.00 x 0
$ 0.80 - $ 0.82
$ 0.54 - $ 1.38
326,243
na
54.36M
$ 1.49
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-12-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-09-2023 12-31-2022 10-K
6 11-02-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 03-10-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-10-2021 03-31-2021 10-Q
13 03-23-2021 12-31-2020 10-K
14 11-25-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

aligos-therapeutics-presents-clinical-data-at-escmid-2024-from-the-alg-097558-phase-1-study
Aligos Therapeutics Presents Clinical Data...
04/25/2024 20:26:40

Data demonstrates a 7-day treatment regimen with the pan-coronavirus protease inhibitor ALG-097558 was well tolerated and does ...

aligos-therapeutics-announces-first-subjects-dosed-in-phase-2a-herald-study-of-alg-055009-in-mash-subjects
Aligos Therapeutics Announces First Subjec...
04/03/2024 12:18:26

earlier-announced-aligos-therapeutics-has-been-awarded-a-13m-nih-contract-to-conduct-clinical-development-of-a-compound-for-the-treatment-of-covid-19
Earlier Announced, Aligos Therapeutics Has...
04/01/2024 15:31:25

https://www.fpds.gov/common/jsp/LaunchWebPage.jsp?command=execute&requestid=172813877&version=1.5

aligos-therapeutics-presents-clinical-data-at-apasl-2024-from-alg-055009-and-alg-000184-phase-1-studies
Aligos Therapeutics Presents Clinical Data...
03/27/2024 12:06:58

Aligos Therapeutics, Inc. (NASDAQ:ALGS, ", Aligos", )))), a clinical stage biopharmaceutical company focused on develop...

aligos-therapeutics-announces-initiation-of-phase-2a-herald-study-of-alg-055009-in-mash-subjects
Aligos Therapeutics Announces Initiation O...
03/18/2024 12:01:17

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
03/15/2024 21:33:52

recap-aligos-therapeutics-q4-earnings
Recap: Aligos Therapeutics Q4 Earnings
03/12/2024 20:30:33

aligos-therapeutics-q4-2023-gaap-eps-022-beats-027-estimate-sales-2009m-beat-1600m-estimate
Aligos Therapeutics Q4 2023 GAAP EPS $(0.2...
03/12/2024 20:26:30

Aligos Therapeutics (NASDAQ:ALGS) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $...

earnings-scheduled-for-march-12-2024
Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

aligos-therapeutics-earnings-preview
Aligos Therapeutics Earnings Preview
03/11/2024 18:00:49

aligos-therapeutics-to-host-kol-event-to-discuss-phase-2a-herald-study-of-alg-055009-in-mash-on-march-7-2024
Aligos Therapeutics To Host KOL Event To D...
02/20/2024 13:30:57

Aligos Therapeutics, Inc. (NASDAQ:ALGS, "Aligos")))), a clinical stage biopharmaceutical company focused on developing ...

why-hello-group-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket
Why Hello Group Shares Are Trading Higher ...
12/08/2023 13:05:42

Shares of Hello Group Inc. (NASDAQ: MOMO) jumped in pre-market trading after reporting results for the third quarter.

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
12/07/2023 21:31:07

aligos-therapeutics-presents-clinical-data-at-hep-dart-2023-from-phase-1-studies-in-hbv-and-nash
Aligos Therapeutics Presents Clinical Data...
12/07/2023 21:18:11

Aligos Therapeutics, Inc. (NASDAQ:ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to...

why-applied-uv-shares-are-trading-higher-by-around-96-here-are-20-stocks-moving-premarket
Why Applied UV Shares Are Trading Higher B...
11/20/2023 13:19:26

Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results.

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
11/20/2023 13:06:36

aligos-therapeutics-inc-files-prospectus-related-to-resale-from-time-to-time-of-up-to-1687m-shares-of-common-stock-by-selling-securityholders
Aligos Therapeutics Inc Files Prospectus R...
11/17/2023 21:42:25

- SEC Filing

aligos-therapeutics-presents-clinical-and-nonclinical-data-at-the-aasld-liver-meeting2023-demonstrating-that-alg-055009-has-a-favorable-risk-benefit-profile
Aligos Therapeutics Presents Clinical And ...
11/13/2023 13:05:09

aligos-therapeutics-presents-data-at-the-aasld-liver-meeting-2023-demonstrating-that-treatment-with-alg-000184-results-in-significant-multi-log-reductions-in-hepatitis-b-antigens
Aligos Therapeutics Presents Data At The A...
11/10/2023 13:10:33

Hepatitis B virus e antigen positive (HBeAg+) subjects dosed with once-daily 300mg ALG-000184 + entecavir for up to 48 weeks de...

aligos-therapeutics-to-present-multiple-posters-at-aaslds-the-liver-meeting-2023-highlighting-progress-for-its-clinical-stage-portfolio-including-lead-thr--agonist-for-the-treatment-of-nash-alg-055009-alg-000184-the-companys-lead-cam-e-molecule
Aligos Therapeutics To Present Multiple Po...
11/07/2023 13:08:07

Aligos Therapeutics, Inc. (NASDAQ:ALGS, "Aligos")))), a clinical stage biopharmaceutical company focused on developing ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION